Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading ->
A significant surge in COVID-19 cases is currently taking place across Europe, something that Hans Kluge, WHO Regional Director for Europe, described as the “fall/winter surge” in a press briefing Thursday. Europe has reported its highest weekly number of COVID-19 cases since the beginning of the pandemic, with nearly 700,000 cases.  Even though mortality rates […] Continue reading ->
  A sweeping proposal by India and South Africa to suspend the protection of intellectual property (IP) related to COVID-19 health products is set to come before the The World Trade Organization’s TRIPS Council this week.  The closed door discussion lays the groundwork for what could prove to  be the most significant public debate over […] Continue reading ->
A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading ->
WHO issued a stiff warning to Covid-skeptics who have been saying that in the absence of a vaccine, policies that let the SARS-CoV-2 virus spread freely would lead to eventual “herd immunity” , and that might be preferable to continued containment and social-distancing measures.  “Herd immunity is a concept used for vaccination, in which a […] Continue reading ->
Acting on the advice of experts, the United States Food and Drug Administration on Tuesday issued new safety-focused guidelines for approval of new COVID-19 vaccines, that would almost certainly delay their emergency approval until after the November Presidential elections. Just hours after the rules were issued, United States President Donald Trump accused the FDA of […] Continue reading ->